National University Cancer Institute, Singapore
In research, National University Cancer Institute, Singapore stands highest in Medicine (#2,605 of 10,443 worldwide), Life Sciences (#2,334 of 7,800 worldwide) and Health Sciences (#3,595 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Molecular Biology — Oncology is 12.2× its share of world research.
- World rank, 2022–2025
- #4,478 of 28,054 · #5,288 all time
- Rank in Singapore
- #17 of 84
- Research works
- 1.3k ▲ 19% vs 2013–17
- Citations
- 51k 39.1 per fractional work
- Top-10% rate
- 23.5% record average 16.5%
- Open access
- 53% world 28%
What is National University Cancer Institute, Singapore known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #2,605 of 10,443 | 20.9% | 180 | #2470 | |
| Life SciencesDomain | #2,334 of 7,800 | 25.4% | 106 | #2562 | |
| Health SciencesDomain | #3,595 of 11,982 | 21.0% | 186 | #3166 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,005 of 3,579 | 25.4% | 88 | #2336 |
Each strip is that field’s whole ranked pool, with the notch where National University Cancer Institute, Singapore sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#2,470 #2,605
- Life Sciences#2,562 #2,334
- Health Sciences#3,166 #3,595
- Biochemistry, Genetics and Molecular Biology#2,336 #2,005
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does National University Cancer Institute, Singapore specialise in?
Where its research is concentrated relative to its size: Oncology takes 12.2× the share of its output that it takes of world research.
- OncologySubfield · 45.4 works12×
- Molecular BiologySubfield · 57.0 works5.7×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.0×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 5.0×
- Immunology and Microbiology 4.0×
- Medicine 2.8×
- Dentistry 0.6×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Health Professions 0.5×
- Materials Science 0.4×
- Neuroscience 0.4×
- Chemistry 0.4×
- Economics, Econometrics and Finance 0.4×
- Physics and Astronomy 0.3×
- Nursing 0.3×
- Mathematics 0.3×
- Engineering 0.3×
- Decision Sciences 0.2×
- Psychology 0.2×
- Energy 0.2×
- Environmental Science 0.2×
- Computer Science 0.1×
- Chemical Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Veterinary 0.1×
- Business, Management and Accounting 0.1×
- Earth and Planetary Sciences 0.1×
- Social Sciences 0.1×
- Arts and Humanities 0.0×
Who are the top researchers at National University Cancer Institute, Singapore?
Ranked on the composite score, Wee Joo Chng, Cheng Ean Chee and Soo Chin Lee lead among researchers whose main affiliation is National University Cancer Institute, Singapore.
- 1 Wee Joo Chng Singapore · #21,085 worldwide 814 citations · 99 works
- 2 Cheng Ean Chee Singapore · #234,529 worldwide 162 citations · 24 works
- 3 Soo Chin Lee Singapore · #341,386 worldwide 126 citations · 41 works
- 4 Balamurugan Vellayappan Singapore · #499,570 worldwide 49 citations · 21 works
- 5 Ross A. Soo Singapore · #660,688 worldwide 175 citations · 99 works
- 6 David S.P. Tan Singapore · #667,402 worldwide 67 citations · 58 works
- 7 Ying Li Singapore · #708,980 worldwide 85 citations · 52 works
- 8 Lingzhi Wang Singapore · #741,262 worldwide 51 citations · 28 works
- 9 Takaomi Sanda Singapore · #773,503 worldwide 46 citations · 21 works
- 10 Joline S.J. Lim Singapore · #811,949 worldwide 43 citations · 19 works
Which keywords describe research at National University Cancer Institute, Singapore?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Cancer, Immunotherapy, Prognostic Factors, Radiotherapy, Targeted Therapy, Tumor Microenvironment and Cancer Therapy.
- Molecular Subtypes
- EGFR Mutations
- ALK Inhibitors
- Minimal Residual Disease
- Immunity
- Mutational Signatures
- Cancer Genomics
- Cell-Free DNA
- Transcriptional Regulation
- Immune Checkpoint Blockade
- PET Imaging
- Survival Analysis
- Breast Cancer
- Metastasis
- Biomarkers
- Clinical Trials
- Tumor Microenvironment
- Targeted Therapy
- Prognostic Factors
- Cancer
- Chemotherapy
- Immunotherapy
- Radiotherapy
- Inflammation
- Cancer Therapy
- Clinical Practice Guidelines
- Gene Expression
- Genomic Instability
- Lymphoma
- Precision Medicine
- Neoadjuvant Therapy
- PD-1 and PD-L1
- Cancer Progression
- Somatic Mutations
- Epigenetic Regulation
- Genomic Profiling
- Cancer Immunotherapy
- Proteasome Inhibitors
- Cell Death
- Treatment Guidelines
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy30▲ 13×22 topics
- Cancer28▲ 6.2×45 topics
- Immunotherapy21▲ 8.9×15 topics
- Prognostic Factors20▲ 14×13 topics
- Radiotherapy18▲ 14×12 topics
- Targeted Therapy18▲ 24×4 topics
- Inflammation18▲ 2.6×56 topics
- Tumor Microenvironment17▲ 12×8 topics
- Cancer Therapy15▲ 7.9×14 topics
- Clinical Trials15▲ 6.7×9 topics
- Clinical Practice Guidelines14▲ 7.9×12 topics
- Biomarkers13▲ 5.7×14 topics
- Gene Expression12▲ 5.7×14 topics
- Metastasis12▲ 10×11 topics
- Genomic Instability10▲ 27×3 topics
- Breast Cancer10▲ 12×10 topics
- Lymphoma10▲ 18×4 topics
- Survival Analysis10▲ 11×7 topics
- Precision Medicine9▲ 5.9×7 topics
- PET Imaging9▲ 15×4 topics
- Neoadjuvant Therapy8▲ 11×5 topics
- Immune Checkpoint Blockade8▲ 22×1 topic
- PD-1 and PD-L18▲ 22×1 topic
- Transcriptional Regulation8▲ 15×8 topics
- Cancer Progression8▲ 13×8 topics
- Cell-Free DNA8▲ 24×2 topics
- Somatic Mutations8▲ 28×2 topics
- Cancer Genomics8▲ 32×1 topic
- Epigenetic Regulation8▲ 11×5 topics
- Mutational Signatures8▲ 32×1 topic
- Genomic Profiling8▲ 22×2 topics
- Immunity7▲ 5.5×9 topics
- Cancer Immunotherapy7▲ 14×3 topics
- Minimal Residual Disease7▲ 30×2 topics
- Proteasome Inhibitors7▲ 29×2 topics
- ALK Inhibitors6▲ 30×1 topic
- Cell Death6▲ 8.1×6 topics
- EGFR Mutations6▲ 30×1 topic
- Treatment Guidelines6▲ 8.8×2 topics
- Molecular Subtypes6▲ 22×3 topics
Which research topics does National University Cancer Institute, Singapore publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations and RNA modifications and cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 8 works
- 2 Cancer Genomics and Diagnostics Cancer Research 8 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 6 works
- 4 RNA modifications and cancer Molecular Biology 5 works
- 5 Multiple Myeloma Research and Treatments Hematology 5 works
- 6 Protein Degradation and Inhibitors Molecular Biology 5 works
- 7 CAR-T cell therapy research Oncology 4 works
- 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 4 works
- 9 Acute Myeloid Leukemia Research Hematology 4 works
- 10 Immune Cell Function and Interaction Immunology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has National University Cancer Institute, Singapore's research output changed?
Output in 2018–2022 was 19% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Singapore
- National University of Singapore
- Nanyang Technological University
- Agency for Science, Technology and Research
- Singapore General Hospital
- Singapore Management University
- National University Hospital
- Institute for Infocomm Research
- Singapore University of Technology and Design
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.